Skip to main content
Login
User menu
Mega menu
EASL.eu
Resources
Resources
EASL Resources
All Resources
Basic Techniques in Experimental Hepatology at a Glance
Clinical Practice Guidelines
Congress Resources
COVID-19 Resources
EASL Molecular Tumour Boards
EASL Genetic Grand Round
EASL Policy Dialogues
EASL Quiz
ePosters
EASL DeepDive
EASL Journal Club
Nurses and AHPs
Online Courses
On-demand Webinars
Podcasts
Slide Decks
Webcasts
Webinars Calendar
EASL-Related Resources
EHC On-demand Webinar
ERN Rare-Liver On-demand Webinars
Baveno VII - Consensus Workshop
Baveno VII - Pediatric Research Workshop
Industry Resources
All Resources
Industry Symposia - EASL Monothematic Conference 2023
Industry Symposia - EASL Congress
Industry Symposia - EASL Liver Cancer Summit
Industry Symposia - EASL SLD Summit
GSK Resources
Patient Resources
All Resources
COVID-19 Resources
Documents
ePosters
Infographics
Patient Guidelines
Podcasts
Slide Decks
Takeaways
Webcasts
EASL Studio
EASL Campus Connect
My Community
Explore Community
EASL Community Feed
All Topics
Community FAQ's
Create
Our Sponsors
Primary tabs
User menu
Resources 85
(current)
Session 85
Displaying 61 - 72 of 85
Display:
12
24
48
Immune-Mediated and Cholestatic Diseases
CymaBay Therapeutics: Taking Aim at Primary Biliary Cholangitis (Complete Session)
Webcasts
View
Immune-Mediated and Cholestatic Diseases
A Life With Primary Biliary Cholangitis (PBC)
Webcasts
View
Immune-Mediated and Cholestatic Diseases
Treatment Goals for PBC
Webcasts
View
Immune-Mediated and Cholestatic Diseases
Updates in PBC Emerging Therapies
Webcasts
View
Immune-Mediated and Cholestatic Diseases
PBC Patient Case in Context
Webcasts
View
Immune-Mediated and Cholestatic Diseases
Q&A and Panel Discussion
Webcasts
View
Viral Hepatitis
Introduction
Webcasts
View
Viral Hepatitis
Biotest: "Decoding the Best Strategies for Post-Transplant HBV Recurrence Prevention" (Complete Session)
Webcasts
View
Viral Hepatitis
Benefits of HBIG+NA prophylactic therapy post-LT
Webcasts
View
Viral Hepatitis
Is NA monotherapy sufficient for prevention of HBV recurrence post-LT?
Webcasts
View
Viral Hepatitis
Debate/ Q&A
Webcasts
View
Metabolism, Alcohol & Toxicity
The Growing Burden of MASLD/MASH: A Call to Action
Webcasts
View
Pagination
First page
« First
Previous page
‹ previous
Page
1
Page
2
Page
3
Page
4
Page
5
Current page
6
Page
7
Page
8
Next page
next ›
Last page
Last »
Explore Community
Community Stream
Easl Community Feed
My Feed
Browse Stream
©2019 - EASL. All Rights Reserved. Powered by
Enovation
.
Footer menu
Content Access policy
Privacy Policy
Cookie Policy